Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Labor Epidural Analgesia and Mother-Infant Bonding After Vaginal Delivery

30. maj 2026 opdateret af: Aysenur Dostbil, Ataturk University

Association Between Postpartum Recovery Quality Measured by ObsQoR-10 and Mother-Infant Bonding After Vaginal Delivery: The Role of Labor Epidural Analgesia

This prospective observational cohort study aims to evaluate the association between postpartum recovery quality and mother-infant bonding in women undergoing vaginal delivery. Postpartum recovery quality will be assessed using the Obstetric Quality of Recovery-10 (ObsQoR-10) questionnaire, and mother-infant bonding will be evaluated using the Postpartum Bonding Questionnaire (PBQ).

Participants will be grouped according to routine clinical labor analgesia preference: women receiving labor epidural analgesia and women not receiving epidural analgesia. Additional assessments will include postpartum pain intensity, anxiety, depressive symptoms, and birth satisfaction.

Baseline psychological assessments will be performed before delivery. The primary postpartum evaluation will be conducted between 6 and 24 hours after delivery. Exploratory follow-up assessments will be performed by telephone during postpartum week 2.

The study aims to better understand the relationship between labor analgesia, postpartum recovery, and early mother-infant bonding outcomes after vaginal delivery.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

This single-center prospective observational cohort study will be conducted at Atatürk University Research Hospital. The study will include term pregnant women planning vaginal delivery.

Participants will be classified into two cohorts according to routine clinical labor analgesia preference:

Women receiving labor epidural analgesia Women not receiving labor epidural analgesia No experimental intervention will be applied as part of the study protocol. Epidural analgesia, when used, will be administered according to routine clinical practice.

Primary Objective:

To evaluate the association between postpartum recovery quality measured using the ObsQoR-10 questionnaire and mother-infant bonding measured using the Postpartum Bonding Questionnaire (PBQ), and to investigate the role of labor epidural analgesia in this relationship.

Secondary Objectives:

To compare postpartum recovery quality between cohorts To compare mother-infant bonding outcomes between cohorts To evaluate postpartum pain, anxiety, depressive symptoms, and birth satisfaction To assess the association between obstetric variables and postpartum recovery outcomes

Assessments:

Prepartum:

STAIS-5 EPDS

Early postpartum period (6-24 hours):

ObsQoR-10 PBQ STAIS-5 EPDS Pain score (VAS/NRS) Birth satisfaction Likert scale

Postpartum week 2:

PBQ EPDS Participants will provide written informed consent before enrollment. All collected data will be anonymized and analyzed confidentially.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

140

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

  • Navn: Ayşenur Dostbil, Associate Professor
  • Telefonnummer: +90 533 367 66 96
  • E-mail: adostbil@hotmail.com

Undersøgelse Kontakt Backup

  • Navn: Ayşe Ceren Hilal Güven, assistant doctor
  • Telefonnummer: +90 554 112 25 81
  • E-mail: achg1995@gmail.com

Studiesteder

  • Tyrkiet (Türkiye)
      • Erzurum, Tyrkiet (Türkiye), 25000
        • Ataturk University
        • Kontakt:
          • Ayşe Ceren Hilal Güven, assistant doctor
          • Telefonnummer: 554-112-25-81
          • E-mail: achg1995@gmail.com

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ingen

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Women with term singleton pregnancy planning vaginal delivery at Atatürk University Research Hospital will be enrolled. Participants will be grouped according to routine clinical labor epidural analgesia preference.

Beskrivelse

Inclusion Criteria:

  • Female participants aged 18 to 40 years
  • Term singleton pregnancy (≥37 weeks)
  • Planned vaginal delivery
  • ASA physical status II
  • Ability to understand Turkish
  • Written informed consent

Exclusion Criteria:

  • Contraindications to epidural analgesia including coagulopathy, anticoagulant use, infection, or increased intracranial pressure
  • Cesarean delivery
  • High-risk pregnancy
  • Neonatal intensive care unit requirement
  • Major depressive disorder
  • Anxiety disorder
  • Current psychotropic medication use

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Labor Epidural Analgesia
Women undergoing vaginal delivery with labor epidural analgesia as part of routine clinical care. Participants will undergo postpartum recovery, mother-infant bonding, anxiety, depression, pain, and birth satisfaction assessments during the postpartum period.
Procedure: Labor Epidural Analgesia
Epidural analgesia administered during labor as part of routine clinical care for pain management during vaginal delivery.
No Labor Epidural Analgesia
Women undergoing vaginal delivery without labor epidural analgesia as part of routine clinical care. Participants will be evaluated for postpartum recovery quality, mother-infant bonding, anxiety, depressive symptoms, pain intensity, and birth satisfaction during the postpartum period.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Mother-Infant Bonding Score
Tidsramme: 6 to 24 hours after vaginal delivery
Mother-infant bonding will be assessed using the Postpartum Bonding Questionnaire (PBQ), a 25-item scale with a total score ranging from 0 to 125. Lower scores indicate better mother-infant bonding, while higher scores indicate poorer bonding.
6 to 24 hours after vaginal delivery

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Postpartum Recovery Quality Score
Tidsramme: 6 to 24 hours after vaginal delivery
Postpartum recovery quality will be assessed using the Obstetric Quality of Recovery-10 (ObsQoR-10) questionnaire. Higher scores indicate better postpartum recovery quality.
6 to 24 hours after vaginal delivery
Postpartum Pain Intensity
Tidsramme: 6 to 24 hours after vaginal delivery
Postpartum pain intensity will be assessed using the Visual Analog Scale (VAS) or Numeric Rating Scale (NRS).
6 to 24 hours after vaginal delivery
Postpartum Anxiety Level
Tidsramme: 6 to 24 hours after vaginal delivery
Postpartum anxiety level will be assessed using the STAIS-5 questionnaire.
6 to 24 hours after vaginal delivery
Postpartum Depressive Symptoms
Tidsramme: 6 to 24 hours after vaginal delivery
Postpartum depressive symptoms will be assessed using the Edinburgh Postnatal Depression Scale (EPDS).
6 to 24 hours after vaginal delivery
Birth Satisfaction Score
Tidsramme: 6 to 24 hours after vaginal delivery
Birth satisfaction will be assessed using a 4-point Likert scale.
6 to 24 hours after vaginal delivery
Mother-Infant Bonding at Postpartum Week 2
Tidsramme: 2 weeks after vaginal delivery
Mother-infant bonding will be reassessed using the Postpartum Bonding Questionnaire (PBQ) during telephone follow-up at postpartum week 2.
2 weeks after vaginal delivery
Postpartum Depressive Symptoms at Week 2
Tidsramme: 2 weeks after vaginal delivery
Postpartum depressive symptoms will be reassessed using the Edinburgh Postnatal Depression Scale (EPDS) during telephone follow-up at postpartum week 2.
2 weeks after vaginal delivery

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Ataturk University

Efterforskere

  • Studiestol: Ayşe Ceren Hilal Güven, assistant doctor, Ataturk University Department of Anesthesiology and Reanimation

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

15. maj 2026

Primær færdiggørelse (Anslået)

16. juni 2029

Studieafslutning (Anslået)

17. juni 2029

Datoer for studieregistrering

Først indsendt

6. maj 2026

Først indsendt, der opfyldte QC-kriterier

6. maj 2026

Først opslået (Faktiske)

12. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

3. juni 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

30. maj 2026

Sidst verificeret

1. maj 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • B.30.2.ATA.0.01.00/234
  • 2026/2 (Anden identifikator: Atatürk University Clinical Research Ethics Committee)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Individual participant data will not be publicly shared because of institutional and participant confidentiality policies.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Fødselssmerter

Kliniske forsøg med Labor Epidural Analgesia

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Zambia

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner